Guests - Dave Smith, Betsy Smith, Dr. Mateja De Leonni

Trump Renames Department of Defense as Department of War

President Trump has issued an executive order renaming the US Department of Defense as the Department of War. The order designates "Department of War" as a secondary title for administrative purposes, allowing Defense Secretary Pete Hegseth to adopt the traditional title of Secretary of War in internal and external communications.

Dave Smith, former Pima County GOP chairman, explains the historical significance: "We had the Department of War literally from the beginning till about 1949. Then we saw this pacifist movement within our government that set us up for the Korean War tragedy."

Smith argues that the name change reflects a shift in America's stance toward global threats. "This new attitude, which I love, is let's get this thing back to its original focus and tell the rest of the world don't mess with us."

The move attempts to formalize the name change without requiring an act of Congress, though strict constitutionalists note that formally changing the department would require congressional approval, just as it did in 1949.

Smith believes this sends a message both internally and externally: "When you change your aspect from being Department of War, which sounds pugnacious but also sounds strong, it has an undertone of 'look, if you want to make war on us, we will make war.'"

Critics have suggested that renaming the department runs counter to Trump's aim of receiving the Nobel Peace Prize, but Winn notes that Trump has touted his success in negotiating seven ceasefires in recent months.

Biden Autopan Fiasco Continues

A new story has emerged regarding President Biden's autopan controversy. Speaker Mike Johnson revealed today that concerns about Biden's awareness of what he was signing continued throughout his presidency, with a particular focus on clemency petitions signed before he left office.

The latest emails suggest Biden may not have been aware of what he was signing, raising questions about the legitimacy of these clemency actions and the oversight within his administration.

Dave Smith expressed frustration at what he sees as a double standard in accountability: "We saw literally a parade of former Republican personnel cuffed, tried, sent to prison... yet here we are, we see a member of the Democrat Party who went from a hundred thousand dollars of personal wealth to millions overnight, but nothing to see here, let's move along."

Smith continued, "We know 2020 election had issues, and we all ask about it, and then we were told 'how dare you ask, how dare you,' and it was this bizarre overreaction that just enhanced my own theories about a stolen election."

The conversation highlighted concerns about Biden's competence during his final years in office and the apparent lack of accountability for administration officials involved in the autopan controversy.

RFK Jr. Takes on Big Pharma in Senate Hearing

Robert F. Kennedy Jr. made headlines by confronting Senator Elizabeth Warren about allegedly taking nearly a million dollars from pharmaceutical companies during a contentious Senate hearing.

Kennedy effectively challenged multiple senators questioning his stance on vaccines by turning the tables and highlighting their financial ties to the pharmaceutical industry. According to Winn, "The senators came loaded to bury yesterday... but he challenged the pharmaceutical companies because he believes that they have been making large donations."

Dave Smith praised Kennedy's performance: "Yesterday was an amazing event where Kennedy was able to best all these people because he just has a wonderful resident memory. He's able to argue point-to-point, and when he hammers them for 'you made $800,000 from Big Pharma, you did this, you did that,' we couldn't trust this."

Smith expressed surprise at Kennedy's role in the Republican administration: "Who would have thought a Kennedy would be riding in on a Republican administration to save the day? He really has become sort of this white knight to fight these bizarre arguments and protect us against this big pharma event."

Arizona Rep. Yasmin Ansari Under Fire for "Constituent" Comments

Arizona Representative Yasmin Ansari, who replaced Ruben Gallego, has drawn criticism for her comments about whom she considers her constituents.

Betsy Brantner Smith, spokesperson for the National Police Association, explained: "Her constituents in her mind are primarily illegal aliens. She continues to make Arizona famous in the national news because of her embarrassing behavior."

Smith described Ansari as "an Iranian anchor baby" born in Seattle to "illegal parents" who was part of a group of House Democrats that traveled to El Salvador in April to advocate for individuals facing deportation.

According to Smith, Ansari "has been warning people of her quote-unquote constituents when ICE is going to be in the area and has said that she really doesn't give a crap about Arizonans."

When questioned about her definition of constituents, Ansari responded: "It doesn't matter what their legal status is. If somebody is an asylum seeker, if somebody has a heart, if somebody is a U.S. citizen, if somebody lives in the community, I represent them. Constituent does not mean voter. I don't care if these individuals can vote for me. I don't give a s***."

Smith compared Ansari's actions to those of Arizona State Senator Analisa Ortiz, noting that State Senator Jake Hoffman has filed an ethics complaint against Ortiz for similar behavior of warning communities about ICE presence.

"What's happening, Kathleen, is these Democrat politicians are trying to get cops hurt," Smith said. "The National Police Association has called out every single one of them... because they're going to get cops hurt."

Breakthroughs in Alzheimer's and Dementia Treatment

Dr. Matea De Leonni of Vita Medical Institute joined the program with her patient Sharon Carson to discuss groundbreaking treatments for Alzheimer's disease.

Carson was the first patient in the United States to receive the Kisumla therapy after FDA approval in July 2023. After receiving treatments every other week for a year, testing revealed remarkable results. "We were able to eliminate the plaque completely from the brain at 12 months, and we saw actually reversal and absences of memory loss after a year," Dr. De Leonni explained.

Carson described her experience: "When I started noticing it maybe six months into the treatment, I had no memory loss, I had no senior moments, I had nothing. It was like a miracle." She initially hesitated to share these improvements with Dr. De Leonni because "when you have Alzheimer's, people think you're nuts."

After completing the initial treatment course, Carson began experiencing occasional "senior moments" again, leading Dr. De Leonni to restart treatment. The doctor explained that the FDA has now approved these medications for maintenance treatments based on new evidence showing that "plaque molecules are present in the blood in the serum."

Dr. De Leonni reported impressive results across her practice: "Roughly we are able to stop the disease process in at least 50% of the patients. The other half I would split in 30% where we've actually seen the reversal of the memory loss, and about 20% maybe a little less of patients I have seen some progression of the disease itself."

She emphasized the importance of early intervention: "You have to catch people when they're really mildly affected. That would be my sincerest appeal to anybody that's listening today. I don't care if you think this is aging or not. If you're not sure, now is the first time ever in the history of humankind that we have the tools to determine what is part of normal aging in terms of cognitive changes and what is not."

Dr. De Leonni described how her practice has expanded significantly to meet demand while many other practices are just beginning to navigate the insurance approval process for these treatments. "I feel like I've become such a pro at that unfortunately," she said, noting that she had three court hearings the previous day to advocate for patients seeking diagnostic tests and treatments.

The doctor stressed that while the new medications represent a tremendous breakthrough, they are not the only approach to treatment: "These drugs are not the only answer or not the main answer. It is a huge step forward from where we've ever been in the history of humankind, but patients that I treat, we talk about other ways of decreasing inflammatory processes in the brain, be it with fasting regimens, be it with various supplements."

Dr. De Leonni closed by inviting the community to join her team, "Remember When," for the Walk to End Alzheimer's on October 25th at Reed Park. "We want to make a statement to the community and really to the world that we are very serious, that we have folks who have been cured and folks who are in the process."